Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose versus multi-dose dexamethasone premedication for taxane chemotherapy
IRCT20230412057889N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexamethasone in cancer (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Incidence of severe chemotherapy-related complications, Anorexia and 8 more. Started Jan 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
cancer
Beyond the preview
Go deeper on IRCT20230412057889N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230412057889N1.